Mir-221-3p is also expressed at higher levels in RA synovial tissue and fluid, and inhibits the anti-inflammatory arm of macrophages by suppressing the JAK3/STAT3 axis and increasing the expression of inflammatory mediators such as IL-6 and IL-8 (44). Here, IL6 is linked to rheumatoid arthritis.